Lymphadenopathies in human immunodeficiency virus infection.
Barrionuevo-Cornejo C, Dueñas-Hancco D.
Semin Diagn Pathol. 2018 Jan;35(1):84-91. doi: 10.1053/j.semdp.2017.12.001. Epub 2017 Dec 6.
Acute Human Immunodeficiency Virus Infection.
Moroti Constantinescu VR.
N Engl J Med. 2023 Dec 14;389(24):2276. doi: 10.1056/NEJMicm2306536.
The ATP/P2X7 axis in human immunodeficiency virus infection of macrophages.
Graziano F, Vicenzi E, Poli G.
Curr Opin Pharmacol. 2019 Aug;47:46-52. doi: 10.1016/j.coph.2019.02.006. Epub 2019 Mar 20.
Human Immunodeficiency Virus Infection And Hypertension. Is There a Connection?
Sanidas E, Papadopoulos DP, Velliou M, Tsioufis K, Barbetseas J, Papademetriou V.
Am J Hypertens. 2018 Mar 10;31(4):389-393. doi: 10.1093/ajh/hpx208.
Cardiac Disease Associated with Human Immunodeficiency Virus Infection.
Bloomfield GS, Leung C.
Cardiol Clin. 2017 Feb;35(1):59-70. doi: 10.1016/j.ccl.2016.09.003.
Acute human immunodeficiency virus infection.
Richey LE, Halperin J.
Am J Med Sci. 2013 Feb;345(2):136-42. doi: 10.1097/MAJ.0b013e31825d4b88.
Cardiovascular Disease in the Setting of Human Immunodeficiency Virus Infection.
Pinto DSM, da Silva MJLV.
Curr Cardiol Rev. 2018 Mar 14;14(1):25-41. doi: 10.2174/1573403X13666171129170046.
Human Immunodeficiency Virus Infection: An Update for Pediatricians.
Emmanuel PJ, Mansfield J, Siberry GK.
Pediatr Rev. 2022 Jun 1;43(6):335-346. doi: 10.1542/pir.2020-001644.
Prevalence of Human Immunodeficiency Virus Infection among Tuberculosis Patients in Nepal.
Adhikari N, Bhattarai R, Basnet R, Tinkari BS, Gyawali BN, Joshi LR.
J Nepal Health Res Counc. 2019 Apr 28;17(1):15-20. doi: 10.33314/jnhrc.1768.
Dyslipidemia and cardiovascular risk in human immunodeficiency virus infection.
Kelesidis T, Currier JS.
Endocrinol Metab Clin North Am. 2014 Sep;43(3):665-84. doi: 10.1016/j.ecl.2014.06.003.
